HIV INFECTIONS

This study is testing a counseling program designed to help men living with HIV in Uganda tell their sexual partners about their status. The program includes health education, communication skill-building, and creating a personal disclosure plan. Researchers want to see if this a…

This study provides continued access to HIV treatment for people who completed previous ViiV Healthcare studies and are still benefiting from the medication. It allows participants who don't have local access to the treatment to continue receiving it while researchers collect add…

This study is testing whether a coaching program called WeCare can help men who have sex with men in South Africa better manage their mental health and stick to their HIV prevention or treatment medications. The program combines problem-solving therapy with practical skills for t…

This early-stage study is testing whether the cancer medication dasatinib can reduce the hidden HIV that persists in the body even during effective treatment. Fourteen adults with well-controlled HIV on long-term therapy will take either dasatinib or a placebo pill for 12 weeks. …

This study is testing whether daily cookies made with Golden Rice and red betel leaf can help lower high blood sugar and improve quality of life in adults living with HIV. Researchers will compare these special cookies to regular cookies over 28 days. The goal is to find a safe, …

This study is developing and testing a counseling program for people with HIV in South Africa. The program aims to help participants manage common, interconnected struggles like depression, trauma, and food insecurity, which can make it harder to stick to HIV medication. Research…

This study aims to improve support services for adolescents and young adults after sexual assault. Researchers will work with survivors and community advisors to design better services that include same-day HIV prevention medication and substance use screening. They will then tes…

This study aims to see if women are better at taking their daily medication when it's combined into one pill instead of two. It will compare a single pill that prevents both HIV and pregnancy against taking two separate pills for the same purposes. Researchers will measure how co…

This study is testing a new program called PrEPwise, designed to help Black women in Virginia decide whether to start taking PrEP, a daily pill that is highly effective at preventing HIV. The program uses community health workers to provide culturally sensitive education and supp…

This study tests whether combining a long-acting HIV prevention shot with extended-release opioid addiction medication works better than daily pills for people transitioning from jail back to the community. Researchers will enroll 300 adults with opioid use disorder who are HIV-n…

This study is testing whether an automated AI chatbot can encourage men to get tested for HIV. 80 men in Malaysia will be randomly assigned to either use the chatbot or receive standard educational materials. The chatbot sends personalized messages with information and motivation…

This study aims to see if offering HIV prevention medications (PrEP and PEP) and routine STI testing at retail pharmacies is a practical and effective way to protect young women in Kenya. It will involve 720 young women seeking contraception and compare different combinations of …

This study aims to test the safety and how the drug cabotegravir works in the bodies of newborns exposed to HIV. It will involve 66 healthy babies born to mothers with HIV, who will receive either oral or injectable forms of the drug. The main goal is to gather information to pot…

This study aims to see how well people in real-world clinics stick with a long-acting injectable drug called lenacapavir to prevent HIV. It will follow 3000 people across the United States for up to two years to understand how they start, use, and sometimes stop this prevention m…

This study is testing an experimental HIV vaccine in infants born to mothers with HIV, but who are not infected themselves. The main goals are to see if the vaccine is safe and if it triggers a protective immune response in the babies. This is an early-stage trial with a small gr…

This study aims to understand if two safe dietary supplements—a specific probiotic or blueberry extract—can affect markers of immune system aging in people with HIV who drink alcohol. It is a research study, not a treatment trial. Participants will try each supplement for four we…